Development of a VX2 Pancreatic Cancer Model in Rabbits: A Pilot Study

Aaron C. Eifler, Robert J Lewandowski, Sumeet Virmani, Johnathan C. Chung, Dingxin Wang, Richard L. Tang, Barbara Szolc-Kowalska, Gayle E Woloschak, Guang-Yu Yang, Robert K. Ryu, Riad Salem, Andrew Christian Larson, Eric C Cheon, Matthew Strouch, David Jason Bentrem, Reed A. Omary*

*Corresponding author for this work

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: An animal model of pancreatic cancer that is large enough to permit imaging and catheterization would be desirable for interventional radiologists to develop novel therapies for pancreatic cancer. The purpose of this study was to test the hypothesis that the VX2 rabbit model of pancreatic cancer could be developed as a suitable platform to test future interventional therapies. Materials and Methods: The authors implanted and grew three pancreatic VX2 tumors per rabbit in six rabbits. Magnetic resonance (MR) imaging was performed at 2 weeks to confirm tumor growth. At 3 weeks, the authors selectively catheterized the gastroduodenal artery under guidance of x-ray digital subtraction angiography (DSA). T2-weighted anatomic imaging, diffusion-weighted MR imaging, and transcatheter intraarterial perfusion (TRIP) MR imaging were then performed. After imaging, tumors were confirmed at necropsy and histopathologically. Tumor sizes at 2 and 3 weeks were compared with a paired t test (P = .05). Results: VX2 pancreatic tumors were grown in all six rabbits. The difference between tumor sizes at 2 and 3 weeks (1.29 cm ± 0.39 vs 1.91 cm ± 0.50, respectively) was significant (P < .001). All tumors were confirmed to be located within pancreatic tissue via histopathologic analysis. DSA and TRIP MR imaging were successful in five rabbits. Diffusion-weighted and anatomic MR imaging were successful in all six rabbits. Conclusions: The VX2 rabbit model of pancreatic cancer is feasible, as verified by imaging and pathologic correlation, and may be a suitable platform to test future interventional therapies.

Original languageEnglish (US)
Pages (from-to)1075-1082
Number of pages8
JournalJournal of Vascular and Interventional Radiology
Volume20
Issue number8
DOIs
StatePublished - Aug 1 2009

Fingerprint

Pancreatic Neoplasms
Rabbits
Neoplasms
Digital Subtraction Angiography
Magnetic Resonance Angiography
Magnetic Resonance Imaging
Diffusion Magnetic Resonance Imaging
Catheterization
Therapeutics
Animal Models
Arteries
X-Rays
Growth

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Eifler, Aaron C. ; Lewandowski, Robert J ; Virmani, Sumeet ; Chung, Johnathan C. ; Wang, Dingxin ; Tang, Richard L. ; Szolc-Kowalska, Barbara ; Woloschak, Gayle E ; Yang, Guang-Yu ; Ryu, Robert K. ; Salem, Riad ; Larson, Andrew Christian ; Cheon, Eric C ; Strouch, Matthew ; Bentrem, David Jason ; Omary, Reed A. / Development of a VX2 Pancreatic Cancer Model in Rabbits : A Pilot Study. In: Journal of Vascular and Interventional Radiology. 2009 ; Vol. 20, No. 8. pp. 1075-1082.
@article{2bd1ce97be0f4ac3afbe1d0f31512e55,
title = "Development of a VX2 Pancreatic Cancer Model in Rabbits: A Pilot Study",
abstract = "Purpose: An animal model of pancreatic cancer that is large enough to permit imaging and catheterization would be desirable for interventional radiologists to develop novel therapies for pancreatic cancer. The purpose of this study was to test the hypothesis that the VX2 rabbit model of pancreatic cancer could be developed as a suitable platform to test future interventional therapies. Materials and Methods: The authors implanted and grew three pancreatic VX2 tumors per rabbit in six rabbits. Magnetic resonance (MR) imaging was performed at 2 weeks to confirm tumor growth. At 3 weeks, the authors selectively catheterized the gastroduodenal artery under guidance of x-ray digital subtraction angiography (DSA). T2-weighted anatomic imaging, diffusion-weighted MR imaging, and transcatheter intraarterial perfusion (TRIP) MR imaging were then performed. After imaging, tumors were confirmed at necropsy and histopathologically. Tumor sizes at 2 and 3 weeks were compared with a paired t test (P = .05). Results: VX2 pancreatic tumors were grown in all six rabbits. The difference between tumor sizes at 2 and 3 weeks (1.29 cm ± 0.39 vs 1.91 cm ± 0.50, respectively) was significant (P < .001). All tumors were confirmed to be located within pancreatic tissue via histopathologic analysis. DSA and TRIP MR imaging were successful in five rabbits. Diffusion-weighted and anatomic MR imaging were successful in all six rabbits. Conclusions: The VX2 rabbit model of pancreatic cancer is feasible, as verified by imaging and pathologic correlation, and may be a suitable platform to test future interventional therapies.",
author = "Eifler, {Aaron C.} and Lewandowski, {Robert J} and Sumeet Virmani and Chung, {Johnathan C.} and Dingxin Wang and Tang, {Richard L.} and Barbara Szolc-Kowalska and Woloschak, {Gayle E} and Guang-Yu Yang and Ryu, {Robert K.} and Riad Salem and Larson, {Andrew Christian} and Cheon, {Eric C} and Matthew Strouch and Bentrem, {David Jason} and Omary, {Reed A.}",
year = "2009",
month = "8",
day = "1",
doi = "10.1016/j.jvir.2009.04.051",
language = "English (US)",
volume = "20",
pages = "1075--1082",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "8",

}

Development of a VX2 Pancreatic Cancer Model in Rabbits : A Pilot Study. / Eifler, Aaron C.; Lewandowski, Robert J; Virmani, Sumeet; Chung, Johnathan C.; Wang, Dingxin; Tang, Richard L.; Szolc-Kowalska, Barbara; Woloschak, Gayle E; Yang, Guang-Yu; Ryu, Robert K.; Salem, Riad; Larson, Andrew Christian; Cheon, Eric C; Strouch, Matthew; Bentrem, David Jason; Omary, Reed A.

In: Journal of Vascular and Interventional Radiology, Vol. 20, No. 8, 01.08.2009, p. 1075-1082.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development of a VX2 Pancreatic Cancer Model in Rabbits

T2 - A Pilot Study

AU - Eifler, Aaron C.

AU - Lewandowski, Robert J

AU - Virmani, Sumeet

AU - Chung, Johnathan C.

AU - Wang, Dingxin

AU - Tang, Richard L.

AU - Szolc-Kowalska, Barbara

AU - Woloschak, Gayle E

AU - Yang, Guang-Yu

AU - Ryu, Robert K.

AU - Salem, Riad

AU - Larson, Andrew Christian

AU - Cheon, Eric C

AU - Strouch, Matthew

AU - Bentrem, David Jason

AU - Omary, Reed A.

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Purpose: An animal model of pancreatic cancer that is large enough to permit imaging and catheterization would be desirable for interventional radiologists to develop novel therapies for pancreatic cancer. The purpose of this study was to test the hypothesis that the VX2 rabbit model of pancreatic cancer could be developed as a suitable platform to test future interventional therapies. Materials and Methods: The authors implanted and grew three pancreatic VX2 tumors per rabbit in six rabbits. Magnetic resonance (MR) imaging was performed at 2 weeks to confirm tumor growth. At 3 weeks, the authors selectively catheterized the gastroduodenal artery under guidance of x-ray digital subtraction angiography (DSA). T2-weighted anatomic imaging, diffusion-weighted MR imaging, and transcatheter intraarterial perfusion (TRIP) MR imaging were then performed. After imaging, tumors were confirmed at necropsy and histopathologically. Tumor sizes at 2 and 3 weeks were compared with a paired t test (P = .05). Results: VX2 pancreatic tumors were grown in all six rabbits. The difference between tumor sizes at 2 and 3 weeks (1.29 cm ± 0.39 vs 1.91 cm ± 0.50, respectively) was significant (P < .001). All tumors were confirmed to be located within pancreatic tissue via histopathologic analysis. DSA and TRIP MR imaging were successful in five rabbits. Diffusion-weighted and anatomic MR imaging were successful in all six rabbits. Conclusions: The VX2 rabbit model of pancreatic cancer is feasible, as verified by imaging and pathologic correlation, and may be a suitable platform to test future interventional therapies.

AB - Purpose: An animal model of pancreatic cancer that is large enough to permit imaging and catheterization would be desirable for interventional radiologists to develop novel therapies for pancreatic cancer. The purpose of this study was to test the hypothesis that the VX2 rabbit model of pancreatic cancer could be developed as a suitable platform to test future interventional therapies. Materials and Methods: The authors implanted and grew three pancreatic VX2 tumors per rabbit in six rabbits. Magnetic resonance (MR) imaging was performed at 2 weeks to confirm tumor growth. At 3 weeks, the authors selectively catheterized the gastroduodenal artery under guidance of x-ray digital subtraction angiography (DSA). T2-weighted anatomic imaging, diffusion-weighted MR imaging, and transcatheter intraarterial perfusion (TRIP) MR imaging were then performed. After imaging, tumors were confirmed at necropsy and histopathologically. Tumor sizes at 2 and 3 weeks were compared with a paired t test (P = .05). Results: VX2 pancreatic tumors were grown in all six rabbits. The difference between tumor sizes at 2 and 3 weeks (1.29 cm ± 0.39 vs 1.91 cm ± 0.50, respectively) was significant (P < .001). All tumors were confirmed to be located within pancreatic tissue via histopathologic analysis. DSA and TRIP MR imaging were successful in five rabbits. Diffusion-weighted and anatomic MR imaging were successful in all six rabbits. Conclusions: The VX2 rabbit model of pancreatic cancer is feasible, as verified by imaging and pathologic correlation, and may be a suitable platform to test future interventional therapies.

UR - http://www.scopus.com/inward/record.url?scp=67651174277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651174277&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2009.04.051

DO - 10.1016/j.jvir.2009.04.051

M3 - Article

C2 - 19560941

AN - SCOPUS:67651174277

VL - 20

SP - 1075

EP - 1082

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 8

ER -